| Pharmaceutical active ingredients: |
| Neostigmine Bromide |
| Available forms, composition and doses of Neostigmina: |
| Tablets; Oral; Neostigmine Bromide 15 mg |
| Neostigmina medical category: |
| Human:Parasympathomemetic (cholinergic) agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| N07AA01 - NeostigmineS01EB06 - Neostigmine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Chile Laboratorios |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Eustigmine | Neostigmine | Unidentified Pharmaceutical Company |
| Fadastigmina | Neostigmine | Fada Pharma |
| Juvastigmin | Neostigmine | Unidentified Pharmaceutical Company |
| Vagostigmine | Neostigmine | Unidentified Pharmaceutical Company |
| Neoeserin | Neostigmine Bromide | Chauvin Ankerpharm |
| Neostigmine | Neostigmine Bromide; Neostigmine Methylsulfate | AstraZeneca |
| Prostigmin | Neostigmine Bromide; Neostigmine Methylsulfate | Valeant Pharmaceuticals; Dermatech Laboratories; Diethelm; ICN Pharmaceuticals; IDS Group; Invida; JDH Pharmaceutical; Medilink; Pharmaforte; Piramal Healthcare; Roche; Transfarma Medica Indah; Zuellig Pharma |
| Syntostigmin | Neostigmine Bromide; Neostigmine Methylsulfate | Sanofi-Aventis |
| Tilstigmin | Neostigmine Bromide; Neostigmine Methylsulfate | Tablets India |
| Normastigmin mit Pilocarpin | Neostigmine Bromide; Pilocarpine Hydrochloride | Sigmapharm Arzneimittel |